Public map story

Cristin Milioti · Playful Mosaic

The global conversation: News pulse 2026-08-26 · The Guardian: The U.S. Food and Drug Administration approves the daraxonrasib drug as a treatment for metastatic pancreatic cancer, making it the first RAS inhibitor drug to be approved for the disease. This came after a previous study showed that it nearly doubled the survival rate for patients compared to chemotherapy. A perspective from Buenos Aires.

announcement · St. Louis, US · 0 likes · 2 replies